EW - Edwards Lifesciences Corp
Close
75.48
0.220 0.291%
Share volume: 60,117
Last Updated: Thu 26 Dec 2024 08:30:01 PM CET
Surgical and Medical Instrument Manufacturing :
1.09%
PREVIOUS CLOSE
CHG
CHG%
$75.26
0.22
0.29%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-28 | 2023-02-13 | 2023-04-28 | 2023-07-28 | 2023-10-27 | 2024-02-12 | 2024-04-29 | 2024-07-31 | |
| Total revenue | 1.319 B | 1.348 B | 1.460 B | 1.530 B | 1.481 B | 1.534 B | 1.598 B | 1.386 B | |
| Cost of revenue | 253.800 M | 257.900 M | 329.500 M | 343.000 M | 350.400 M | 356.900 M | 385.600 M | 285.300 M | |
| Gross profit | 1.065 B | 1.090 B | 1.130 B | 1.187 B | 1.131 B | 1.177 B | 1.213 B | 1.101 B | |
| 2.37% | 3.64% | 5.05% | -4.78% | 4.13% | 3.01% | -9.24% | |||
| Operating expenses | 610.900 M | 643.200 M | 697.500 M | 739.000 M | 709.900 M | 750.000 M | 774.900 M | 723.400 M | |
| Selling general and admin | 377.300 M | 411.000 M | 436.300 M | 468.700 M | 439.600 M | 480.000 M | 489.700 M | 450.800 M | |
| Research and development | 233.600 M | 232.200 M | 261.200 M | 270.300 M | 270.300 M | 270.000 M | 285.200 M | 272.600 M | |
| Total expenses | 864.700 M | 902.200 M | 1.027 B | 1.082 B | 1.060 B | 1.107 B | 1.161 B | 1.009 B | |
| 4.34% | 13.83% | 5.38% | -2.03% | 4.43% | 4.80% | -13.08% | |||
| Operating income | 454.300 M | 446.100 M | 432.600 M | 447.900 M | 420.600 M | 426.800 M | 437.700 M | 377.200 M | |
| Ebit | 454.300 M | 446.100 M | 432.600 M | 447.900 M | 420.600 M | 426.700 M | 437.700 M | 377.200 M | |
| Pretax income | 407.300 M | 459.300 M | 398.600 M | 338.500 M | 439.300 M | 421.700 M | 409.400 M | 386.600 M | |
| 12.77% | -13.22% | -15.08% | 29.78% | -4.01% | -2.92% | -5.57% | |||
| Income tax | 63.800 M | 60.900 M | 58.100 M | 33.000 M | 55.600 M | 52.000 M | 58.400 M | 20.200 M | |
| Net income basic | 343.500 M | 398.400 M | 340.500 M | 305.500 M | 384.900 M | 371.500 M | 351.900 M | 366.300 M | |
| 15.98% | -14.53% | -10.28% | 25.99% | -3.48% | -5.28% | 4.09% | |||
| Net income | 343.500 M | 398.400 M | 340.500 M | 305.500 M | 384.900 M | 371.500 M | 351.900 M | 366.300 M | |
| 15.98% | -14.53% | -10.28% | 25.99% | -3.48% | -5.28% | 4.09% |